Epilepsy clinical trials at UC Davis

1 research study open to eligible people

Therapy In Status Epilepticus
open to eligible people ages 12 years and up
This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).
Sacramento, California and other locations

Last updated: October 14, 2024